This expert-led course provides an overview of pharmacology broken down into five sections.  The first four sections cover cytotoxic therapies, overviewing DNA-damaging agents, microtubule toxins, and antimetabolites.  The fifth section focuses on drug interactions in oncology and their importance in patient care.  

Learning Objectives:

  1. Describe the mechanistic action of different DNA-damaging agents and apply knowledge of DNA-damaging agents to anticipate side effects and learn common toxicities;
  2. Describe the mechanistic action of different microtubule toxins and antimetabolites and apply knowledge of microtubule toxins and antimetabolites to anticipate side effects and learn common toxicities; and
  3. Briefly describe pathways of drug-drug interactions in oncology.

ACGME Competencies: 

  • Medical Knowledge

Institute of Medicine (IOM) Competencies: 

  • Working as a part of interprofessional teams
  • Delivering patient-centered care
  • Practicing evidence-based medicine 

IMPORTANT NOTE: This course expires on March 23, 2019. Participants must complete all necessary course components by this date to be eligible to claim CME credit.

2.5 Credits/Points are available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits
  • ABIM MOC Points
  • CNE Contact Hours
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted. 
  • Certificate of Completion may be used to document participation, but no credit will be conferred.